Serum From Patients With Severe Heart Failure Downregulates eNOS and Is Proapoptotic : Role of Tumor Necrosis Factor-

Circulation - United States
doi 10.1161/01.cir.100.19.1983
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Serum Concentration of Visfatin Is Decreased in Patients With Chronic Heart Failure.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2012English

ST2 in Patients With Severe Aortic Stenosis and Heart Failure

Cardiology Journal
MedicineCardiovascular MedicineCardiology
2013English

HE4 Serum Levels Are Associated With Heart Failure Severity in Patients With Chronic Heart Failure

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2017English

Antioxidants and Tumor Necrosis Factor-Α in Patients With Pulmonary Tuberculosis

Journal of High Institute of Public Health
2010English

Tumor Necrosis Factor- Downregulates Endothelial Nitric Oxide Synthase mRNA Stability via Translation Elongation Factor 1- 1

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2008English

Digoxin Serum Levels in Patients With Chagas' Cardiomyopathy and Heart Failure

Revista da Sociedade Brasileira de Medicina Tropical
ParasitologyInfectious DiseasesMicrobiology
2010English

Tumor Necrosis Factor

2004English

The Patients With Severe Heart Failure: Central Role of Echocardiography in Indication of Optimal Treatment — Two Cases

Cardiologia Croatica
Cardiovascular MedicineCardiology
2013English

Interrelation Between Persistent Necrosis of Cardiomyocytes and Prognosis in Patients With Chronic Heart Failure

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy